Professor Jonathan Stamler's latest findings regarding nitric oxide have the potential to reshape fundamentally the way we think about the respiratory system - and offer new avenues to save lives. It may be time to rewrite the textbooks.
Scientific dogma has the respiration process involving only two elements -- oxygen and carbon dioxide. Specifically, the delivery of oxygen from lungs to tissues, and the removal of the waste product, carbon dioxide, through exhaling.
Recently published online in the journal Proceedings of the National Academy of Sciences (PNAS), Stamler and colleagues demonstrate that nitric oxide is essential for the delivery of oxygen to the cells and tissues that need it.
Stamler, MD, a Professor of Medicine at Case Western Reserve University School of Medicine and Cardiologist at University Hospitals Case Medical Center, led a team that showed that nitric oxide must accompany hemoglobin to enable blood vessels to open and then supply oxygen to tissues.
Doctors have long known that a major disconnect exists between the amount of oxygen carried in the blood and the amount of oxygen delivered to the tissues. Until now, they had no way to explain the discrepancy. The new findings show that nitric oxide within the red blood cell itself is the gatekeeper to the respiratory cycle - nitric oxide makes the cycle run.
"The bottom line is that we have discovered the molecular basis of blood flow control in the respiratory cycle loop," Stamler said. "It's in the hemoglobin protein itself, which has the ability to deliver the nitric oxide together with oxygen. The simplified textbook view of two gases carried by hemoglobin is missing an essential element - nitric oxide - because blood flow to tissues is actually more important in most circumstances than how much oxygen is carried by hemoglobin. So the respiratory cycle is actually a three-gas system."
Stamler's previous research had revealed that the respiratory cycle was more than an oxygen and carbon dioxide exchange proposition. Stamler and colleagues also had shown that red blood cells carry and release nitric oxide, but had not yet explained the exact physiologic ramifications of nitric oxide release.
In this most recent research, investigators uncovered the key role of nitric oxide in controlling the blood flow in small vessels within tissues responsible for delivering oxygen (known as "blood flow autoregulation") - a process whose molecular basis had been a longstanding mystery in medicine. Investigators specifically examined the respiratory cycle in mice lacking the one amino acid site that carries nitric oxide in their red blood cells. Low and behold, blood flow autoregulation was eliminated entirely - the animals could not oxygenate tissues.
Initially, investigators found low oxygen levels in the animals' muscles at baseline, despite the animals' red blood cells carrying a full load of oxygen. When the mice were then stressed to bring on slight oxygen deprivation (hypoxia), the blood flow to their organs dropped precipitously. The lack of oxygen should have prompted a spike in blood flow to send more oxygenated blood to tissues and cells. Instead, the reduced blood flow and ensuing oxygen shortfall triggered heart attacks and heart failure in these nitric oxide-deficient animals.
The experiment demonstrated that the nitric oxide-release mechanism regulates oxygen delivery. When nitric oxide flows from the cysteine-binding site in hemoglobin, blood vessels dilate (stretch) and allow oxygen-carrying red blood cells access to tissues.
"These mice had red blood cells that by all traditional measures are completely normal in carrying oxygen and releasing it and then in picking up carbon dioxide, yet these animals cannot oxygenate their tissues," said Stamler, director of Case Western Reserve's Institute for Transformative Molecular Medicine. "Lacking nitric oxide in red cells, oxygen deficiency could not induce vasodilation, which is essential for sustaining life as we know it."
Historically, the control of blood flow has been thought to be the purview of blood vessels and their endothelial linings, while the role of the red blood cell went unappreciated. Blood flow deficits that cause heart attacks and strokes were thought not to be linked to red blood cells.
"Within the tissues, the tiny vessels and the red blood cells together make up the critical entity controlling blood flow," Stamler said. "Red blood cell dysfunction is likely a hidden contributor to diseases of the heart, lung and blood such as heart attack, heart failure, stroke and ischemic injury to kidneys."
Low nitric oxide levels in red blood cells make blood disorders, such as sickle cell anemia, particularly dangerous. Laboratory research has shown that the red blood cells in individuals with these conditions do not trigger the hypoxic vasodilation required for blood flow autoregulation to work well.
In addition, blood transfusions, which have recently been shown to be deficient in nitric oxide, are associated with increased morbidity and mortality, including heart attacks. The effects of blood transfusions are suspiciously similar to effects seen in the mice, Stamler said. They both lack nitric oxide.
"It's not enough to increase to oxygen content of blood by transfusion; if the nitric oxide mechanism is shot, oxygen cannot make it to its destination," he said. "We know that blood in a blood bank is deficient in nitric oxide, so infusing that blood may cause plugging of blood vessels in tissues, making things worse. Essentially, blood flow cannot autoregulate (increase) without nitric oxide. In terms of developing future therapies, the goal must be restoring red blood cell function, complete with nitric oxide delivery capability. As for the nation's blood supply, the blood should be replenished with nitric oxide."
Stamler also serves as the Director of the Harrington Discovery Institute at University Hospitals Case Medical Center. Joining him in this research were lead author Rongli Zhang and contributing authors Douglas T. Hess, Zhaoxia Qian, Alfred Hausladen, Fabio Fonseca and Ruchi Chaube, all of the department of medicine, and the Institute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, and James D. Reynolds, the department of anesthesiology, University Hospitals Case Medical Center, and the Institute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine.
This research was funded by National Institutes of Health, Defense Advanced Research Projects Agency, Case Western Reserve University School of Medicine and UH Case Medical Center.
About Case Western Reserve University School of Medicine
About Case Western Reserve University School of Medicine
Founded in 1843, Case Western Reserve University School of Medicine is the largest medical research institution in Ohio and is among the nation's top medical schools for research funding from the National Institutes of Health. The School of Medicine is recognized throughout the international medical community for outstanding achievements in teaching. The School's innovative and pioneering Western Reserve2 curriculum interweaves four themes--research and scholarship, clinical mastery, leadership, and civic professionalism--to prepare students for the practice of evidence-based medicine in the rapidly changing health care environment of the 21st century. Nine Nobel Laureates have been affiliated with the School of Medicine.
Annually, the School of Medicine trains more than 800 MD and MD/PhD students and ranks in the top 25 among U.S. research-oriented medical schools as designated by U.S. News & World Report's "Guide to Graduate Education."
The School of Medicine's primary affiliate is University Hospitals Case Medical Center and is additionally affiliated with MetroHealth Medical Center, the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, and the Cleveland Clinic, with which it established the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in 2002. http://casemed.case.edu
About University Hospitals
University Hospitals, the second largest employer in Northeast Ohio with 25,000 employees, serves the needs of patients through an integrated network of 15 hospitals, 29 outpatient health centers and primary care physician offices in 15 counties. At the core of our $3.5 billion health system is University Hospitals Case Medical Center, ranked among America's 50 best hospitals by U.S. News & World Report in all 12 methodology-ranked specialties. The primary affiliate of Case Western Reserve University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and research centers of excellence in the nation, including cancer, pediatrics, women's health, orthopaedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main campus includes UH Rainbow Babies & Children's Hospital, ranked among the top children's hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. For more information, go to http://www.uhhospitals.org
Proceedings of the National Academy of Sciences